Immatics IMTX
NASDAQ IMTX
$8.66 -0.12 (-1.37%)
As of: Oct 1, 2026 · 10:48 AM EDT

Immatics (IMTX) Income - Equity (2023 - 2026)

Updated

Immatics (IMTX) posted Income - Equity of -$72.96 million for Q2 2026, compared with -$80.77 million a year earlier.

Analysis

Immatics (IMTX) Income - Equity (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Income - Equity at Immatics was -$280.59 million.

  • Quarterly Income - Equity has run from a low of -$80.77 million in Q2 2025 to a high of -$1.87 million in Q1 2024 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income - Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Immatics 1.18 Bn -861.08 Mn - -72.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -72.96 Mn
Mar 31, 2026 -67.62 Mn
Sep 30, 2025 -59.24 Mn
Jun 30, 2025 -80.77 Mn
Mar 31, 2025 -42.97 Mn
Sep 30, 2024 -2.58 Mn
Jun 30, 2024 -19.22 Mn
Mar 31, 2024 -1.87 Mn
Sep 30, 2023 -28.84 Mn
Jun 30, 2023 -26.80 Mn
Mar 31, 2023 -21.20 Mn
API Access

Immatics Income - Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-equity&ticker=IMTX&period=max&api_key=YOUR_API_KEY